Gilteritinib with or without venetoclax for relapsed/refractory FLT3-mutated acute myeloid leukaemia
- Eitan Kugler
- , Inbar Cohen
- , Irina Amitai
- , Ron Ram
- , Avraham Frisch
- , Boaz Nachmias
- , Jonathan Canaani
- , Yakir Moshe
- , Baher Krayem
- , Shlomzion Aumann
- , Israel Henig
- , Vladimir Vainstein
- , Liat Shargian
- , Chezi Ganzel
- , Moshe Yeshurun
- , Itay Levi
- , Pia Raanani
- , Luiza Akria
- , Yishai Ofran
- , Shai Shimony
- Rabin Medical Center Israel
- Tel Aviv University
- University of Texas MD Anderson Cancer Center
- Sheba Medical Center at Tel Hashomer
- Tel Aviv Sourasky Medical Center
- Rambam Health Care Campus Israel
- Technion-Israel Institute of Technology
- Hebrew University of Jerusalem
- Cornell University
- Soroka Medical Center
- Dana-Farber Cancer Institute
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations